E3泛素连接酶RNF25在肿瘤发生发展中的研究进展
Research Progress of E3 Ubiquitin Ligase RNF25 in Tumorigenesis and Development
DOI: 10.12677/acm.2026.162694, PDF,   
作者: 周 亮:赣南医科大学第一临床医学院,江西 赣州;叶小英:赣南医科大学第一附属医院皮肤科,江西 赣州
关键词: 环指蛋白25 (RNF25)E3泛素连接酶恶性肿瘤信号通路RING Finger Protein 25 (RNF25) E3 Ubiquitin Ligase Malignant Tumor Signal Pathway
摘要: 环指蛋白25 (RING Finger Protein 25, RNF25)是E3泛素连接酶家族中的重要成员,其功能依赖于特征性的RING结构域。该蛋白能够通过泛素化修饰特定靶蛋白或直接参与信号转导,在细胞凋亡、增殖与迁移等关键生命活动中发挥核心调控作用。近年来研究发现,RNF25在肾细胞癌、非小细胞肺癌、肝细胞癌等多种恶性肿瘤中表达异常,并可通过激活NF-κB、Wnt等重要信号通路或介导底物蛋白降解,参与肿瘤的发生发展、转移及耐药等恶性进程。本文系统梳理RNF25的分子结构及其生物学功能,重点总结其在不同类型肿瘤中的表达模式、调控机制与病理作用,评估其作为肿瘤生物标志物和潜在治疗靶点的临床应用前景,同时指出现有研究的局限性并展望未来研究方向,以期为深入解析肿瘤机制及开发新型诊疗策略提供理论依据。
Abstract: RING finger protein 25 (RNF25) is a key member of the E3 ubiquitin ligase family, whose function is dependent on its characteristic RING domain. This protein can exert core regulatory effects on critical cellular processes, including apoptosis, proliferation, and migration, either by ubiquitinating specific target proteins or directly participating in signal transduction. In recent years, studies have found that RNF25 is abnormally expressed in various malignant tumors such as renal cell carcinoma, non-small cell lung cancer, and hepatocellular carcinoma. It can participate in the malignant progression of tumors, including tumorigenesis, metastasis, and chemoresistance, by activating key signaling pathways like NF-κB and Wnt or mediating the degradation of substrate proteins. This paper systematically summarizes the molecular structure and biological functions of RNF25, focuses on its expression patterns, regulatory mechanisms, and pathological roles in different types of tumors, and evaluates its clinical application prospects as a tumor biomarker and potential therapeutic target. Meanwhile, this paper points out the limitations of existing research and prospects future research directions, aiming to provide a theoretical basis for in-depth analysis of tumor mechanisms and development of novel diagnostic and therapeutic strategies.
文章引用:周亮, 叶小英. E3泛素连接酶RNF25在肿瘤发生发展中的研究进展[J]. 临床医学进展, 2026, 16(2): 2823-2831. https://doi.org/10.12677/acm.2026.162694

参考文献

[1] Mohapatra, G., Eisenberg-Lerner, A. and Merbl, Y. (2021) Gatekeepers of the Gut: The Roles of Proteasomes at the Gastrointestinal Barrier. Biomolecules, 11, Article 989. [Google Scholar] [CrossRef] [PubMed]
[2] Buetow, L. and Huang, D.T. (2016) Structural Insights into the Catalysis and Regulation of E3 Ubiquitin Ligases. Nature Reviews Molecular Cell Biology, 17, 626-642. [Google Scholar] [CrossRef] [PubMed]
[3] Liu, C.H., Goldberg, A.L. and Qiu, X.B. (2007) New Insights into the Role of the Ubiquitin-Proteasome Pathway in the Regulation of Apoptosis. Chang Gung Medical Journal, 30, 469-479.
[4] Daulny, A. and Tansey, W.P. (2009) Damage Control: DNA Repair, Transcription, and the Ubiquitin-Proteasome System. DNA Repair, 8, 444-448. [Google Scholar] [CrossRef] [PubMed]
[5] Mocciaro, A. and Rape, M. (2012) Emerging Regulatory Mechanisms in Ubiquitin-Dependent Cell Cycle Control. Journal of Cell Science, 125, 255-263. [Google Scholar] [CrossRef] [PubMed]
[6] Claustre, A., Malige, M., Macheton, M., Combaret, L., Lefai, E., Fafournoux, P., et al. (2025) Structure Predictions of MuRF1-UBE2 Complexes Identify Amino Acid Residues Governing Interaction Selectivity for Each MuRF1-E2 Pair. The FEBS Journal, 292, 2559-2577. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, Z., Sie, B., Chang, A., Leng, Y., Nardone, C., Timms, R.T., et al. (2023) Elucidation of E3 Ubiquitin Ligase Specificity through Proteome-Wide Internal Degron Mapping. Molecular Cell, 83, 3377-3392.e6. [Google Scholar] [CrossRef] [PubMed]
[8] You, S., Xu, J., Guo, Y., Guo, X., Zhang, Y., Zhang, N., et al. (2024) E3 Ubiquitin Ligase WWP2 as a Promising Therapeutic Target for Diverse Human Diseases. Molecular Aspects of Medicine, 96, Article ID: 101257. [Google Scholar] [CrossRef] [PubMed]
[9] Gundogdu, M. and Walden, H. (2019) Structural Basis of Generic versus Specific E2-RING E3 Interactions in Protein Ubiquitination. Protein Science, 28, 1758-1770. [Google Scholar] [CrossRef] [PubMed]
[10] Toma-Fukai, S. and Shimizu, T. (2021) Structural Diversity of Ubiquitin E3 Ligase. Molecules, 26, Article 6682. [Google Scholar] [CrossRef] [PubMed]
[11] DaRosa, P.A., Harrison, J.S., Zelter, A., Davis, T.N., Brzovic, P., Kuhlman, B., et al. (2018) A Bifunctional Role for the UHRF1 UBL Domain in the Control of Hemi-Methylated DNA-Dependent Histone Ubiquitylation. Molecular Cell, 72, 753-765.e6. [Google Scholar] [CrossRef] [PubMed]
[12] Khago, D., Fucci, I.J. and Byrd, R.A. (2020) The Role of Conformational Dynamics in the Recognition and Regulation of Ubiquitination. Molecules, 25, Article 5933. [Google Scholar] [CrossRef] [PubMed]
[13] Li, S., Liang, Y., Mariano, J., Metzger, M.B., Stringer, D.K., Hristova, V.A., et al. (2015) Insights into Ubiquitination from the Unique Clamp-Like Binding of the RING E3 AO7 to the E2 UbcH5B. Journal of Biological Chemistry, 290, 30225-30239. [Google Scholar] [CrossRef] [PubMed]
[14] Asamitsu, K., Tetsuka, T., Kanazawa, S. and Okamoto, T. (2003) RING Finger Protein AO7 Supports NF-κB-Mediated Transcription by Interacting with the Transactivation Domain of the P65 Subunit. Journal of Biological Chemistry, 278, 26879-26887. [Google Scholar] [CrossRef] [PubMed]
[15] Li, L., Wang, Z.X., et al. (2025) BAY11-7082 Targets RNF25 to Reverse TRIP4 Ubiquitination-Dependent NF-κB Activation and Apoptosis Resistance in Renal Cell Carcinoma. International Journal of Biological Sciences, 21, 4410-4427. [Google Scholar] [CrossRef] [PubMed]
[16] Huang, Z., Zhou, L., Duan, J., Qin, S., Jiang, J., Chen, H., et al. (2024) Oxidative Stress Promotes Liver Cancer Metastasis via RNF25‐Mediated E‐Cadherin Protein Degradation. Advanced Science, 11, Article ID: 2306929. [Google Scholar] [CrossRef] [PubMed]
[17] Cho, J.H., You, Y., Yeom, Y.I., Lee, D.C., Kim, B., Won, M., et al. (2018) RNF25 Promotes Gefitinib Resistance in EGFR-Mutant NSCLC Cells by Inducing NF-κB-Mediated ERK Reactivation. Cell Death & Disease, 9, Article No. 587. [Google Scholar] [CrossRef] [PubMed]
[18] Feng, S., Rao, Z., Zhang, J., She, X., Chen, Y., Wan, K., et al. (2023) Inhibition of CARM1‐Mediated Methylation of ACSL4 Promotes Ferroptosis in Colorectal Cancer. Advanced Science, 10, Article ID: 2303484. [Google Scholar] [CrossRef] [PubMed]
[19] Zuo, H., Chen, L., Li, N. and Song, Q. (2020) Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients with Pancreatic Cancer. Frontiers in Genetics, 11, Article 612196. [Google Scholar] [CrossRef] [PubMed]
[20] Huang, H., Lumpkin, R.J., Tsai, R.W., Su, S., Zhao, X., Xiong, Y., et al. (2024) Ubiquitin-Specific Proximity Labeling for the Identification of E3 Ligase Substrates. Nature Chemical Biology, 20, 1227-1236. [Google Scholar] [CrossRef] [PubMed]
[21] Chiou, L.F., Droby, G.N., Jayaprakash, D., Anand, J.R., Zhang, X., Yang, Y., et al. (2025) The RING Finger E3 Ligase RNF25 Protects DNA Replication Forks Independently of Its Canonical Roles in Ubiquitin Signaling. Nature Communications, 16, Article No. 7214. [Google Scholar] [CrossRef] [PubMed]
[22] Zhao, S., Cordes, J., Caban, K.M., Götz, M.J., Mackens-Kiani, T., Veltri, A.J., et al. (2023) RNF14-Dependent Atypical Ubiquitylation Promotes Translation-Coupled Resolution of RNA-Protein Crosslinks. Molecular Cell, 83, 4290-4303.e9. [Google Scholar] [CrossRef] [PubMed]
[23] Hundley, F.V., Sanvisens Delgado, N., Marin, H.C., Carr, K.L., Tian, R. and Toczyski, D.P. (2021) A Comprehensive Phenotypic CRISPR-Cas9 Screen of the Ubiquitin Pathway Uncovers Roles of Ubiquitin Ligases in Mitosis. Molecular Cell, 81, 1319-1336.e9. [Google Scholar] [CrossRef] [PubMed]
[24] Ding, W., Li, C., Hu, T., Graves-Deal, R., Fotia, A.B., Weissman, A.M., et al. (2008) EGF Receptor-Independent Action of TGF-α Protects Naked2 from AO7-Mediated Ubiquitylation and Proteasomal Degradation. Proceedings of the National Academy of Sciences of the United States of America, 105, 13433-13438. [Google Scholar] [CrossRef] [PubMed]
[25] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[26] Han, S., Wang, R., Zhang, Y., Li, X., Gan, Y., Gao, F., et al. (2022) The Role of Ubiquitination and Deubiquitination in Tumor Invasion and Metastasis. International Journal of Biological Sciences, 18, 2292-2303. [Google Scholar] [CrossRef] [PubMed]
[27] Zhang, Q., Lenardo, M.J. and Baltimore, D. (2017) 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology. Cell, 168, 37-57. [Google Scholar] [CrossRef] [PubMed]
[28] Zhang, C., Yang, Y., Wang, K., Chen, M., Lu, M., Hu, C., et al. (2022) The Systematic Analyses of RING Finger Gene Signature for Predicting the Prognosis of Patients with Hepatocellular Carcinoma. Journal of Oncology, 2022, Article ID: 2466006. [Google Scholar] [CrossRef] [PubMed]
[29] Hayes, J.D., Dinkova-Kostova, A.T. and Tew, K.D. (2020) Oxidative Stress in Cancer. Cancer Cell, 38, 167-197. [Google Scholar] [CrossRef] [PubMed]
[30] Li, J., Wang, X., Hu, J., Shi, M., Zhang, L. and Chen, H. (2019) Combined Treatment with N‐Acetylcysteine and Gefitinib Overcomes Drug Resistance to Gefitinib in NSCLC Cell Line. Cancer Medicine, 9, 1495-1502. [Google Scholar] [CrossRef] [PubMed]
[31] Tsilimigras, D.I., Brodt, P., Clavien, P., Muschel, R.J., D’Angelica, M.I., Endo, I., et al. (2021) Liver Metastases. Nature Reviews Disease Primers, 7, Article No. 27. [Google Scholar] [CrossRef] [PubMed]
[32] Tang, M., Wang, H., Cao, Y., Zeng, Z., Shan, X. and Wang, L. (2020) Nomogram for Predicting Occurrence and Prognosis of Liver Metastasis in Colorectal Cancer: A Population-Based Study. International Journal of Colorectal Disease, 36, 271-282. [Google Scholar] [CrossRef] [PubMed]
[33] Siegel, R.L., Wagle, N.S., Cercek, A., Smith, R.A. and Jemal, A. (2023) Colorectal Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 233-254. [Google Scholar] [CrossRef] [PubMed]
[34] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[35] Zhang, C., Tian, C., Zhu, R., Chen, C., Jin, C., Wang, X., et al. (2025) Circsatb1 Promotes Colorectal Cancer Liver Metastasis through Facilitating FKBP8 Degradation via RNF25‐Mediated Ubiquitination. Advanced Science, 12, e2406962. [Google Scholar] [CrossRef] [PubMed]
[36] Wang, Y., Dai, J., Zeng, Y., Guo, J. and Lan, J. (2021) E3 Ubiquitin Ligases in Breast Cancer Metastasis: A Systematic Review of Pathogenic Functions and Clinical Implications. Frontiers in Oncology, 11, Article 752604. [Google Scholar] [CrossRef] [PubMed]
[37] Bouchal, P., Dvořáková, M., Roumeliotis, T., Bortlíček, Z., Ihnatová, I., Procházková, I., et al. (2015) Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer. Molecular & Cellular Proteomics, 14, 1814-1830. [Google Scholar] [CrossRef] [PubMed]
[38] Lian, J., Liu, C., Guan, X., Wang, B., Yao, Y., Su, D., et al. (2020) Ubiquitin Specific Peptidase 5 Enhances STAT3 Signaling and Promotes Migration and Invasion in Pancreatic Cancer. Journal of Cancer, 11, 6802-6811. [Google Scholar] [CrossRef] [PubMed]
[39] Lim, K. and Joo, J. (2020) Predictive Potential of Circulating Ube2h mRNA as an E2 Ubiquitin-Conjugating Enzyme for Diagnosis or Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences, 21, Article 3398. [Google Scholar] [CrossRef] [PubMed]
[40] Kennedy, C., McPhie, K. and Rittinger, K. (2022) Targeting the Ubiquitin System by Fragment-Based Drug Discovery. Frontiers in Molecular Biosciences, 9, Article 1019636. [Google Scholar] [CrossRef] [PubMed]
[41] Wettergren, E.E., Gussing, F., Quintino, L. and Lundberg, C. (2012) Novel Disease-Specific Promoters for Use in Gene Therapy for Parkinson’s Disease. Neuroscience Letters, 530, 29-34. [Google Scholar] [CrossRef] [PubMed]
[42] Gurzeler, L., Link, M., Ibig, Y., Schmidt, I., Galuba, O., Schoenbett, J., et al. (2023) Drug-Induced ERF1 Degradation Promotes Readthrough and Reveals a New Branch of Ribosome Quality Control. Cell Reports, 42, Article ID: 113056. [Google Scholar] [CrossRef] [PubMed]
[43] Arisi, I., D’Onofrio, M., Brandi, R., Felsani, A., Capsoni, S., Drovandi, G., et al. (2011) Gene Expression Biomarkers in the Brain of a Mouse Model for Alzheimer’s Disease: Mining of Microarray Data by Logic Classification and Feature Selection. Journal of Alzheimers Disease, 24, 721-738. [Google Scholar] [CrossRef] [PubMed]
[44] Biemann, R., Roomp, K., Noor, F., Krishnan, S., Li, Z., Shahzad, K., et al. (2020) Gene Expression Profile of CD14+ Blood Monocytes Following Lifestyle-Induced Weight Loss in Individuals with Metabolic Syndrome. Scientific Reports, 10, Article No. 17855. [Google Scholar] [CrossRef] [PubMed]